A Study of SKB315 in Patients With Advanced Solid Tumors

Clinical trial NCT05367635 · RECRUITING

Trial details

NCT number: NCT05367635
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2022-03-16
Primary completion: 2026-06-30
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.